Liffy Cherian, APRN
Clinical Nurse Specialist · Dallas, TXNPI 1265073225
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Janssen Scientific Affairs, LLC at 25.7% of the total. Reporting peaked in 2022 at $2,182 and has fallen 72.2% since, to $606 in 2025.
Across 20 payments — averaging $151.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$780
- Epizyme, Inc.$713
- Ipsen Biopharmaceuticals, Inc$540
- Adaptive Biotechnologies Corporation$172
- Taiho Oncology, Inc.$168
- Sanofi-aventis U.S. LLC$149
- plus $508 from 7 others
What the payments were for
- Consulting fees$78026%
- Speaking & faculty fees$1,34844%
- Travel & lodging$632%
- Food & beverage$52717%
- Education$31210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 1 | $780 |
| Epizyme, Inc. | 3 | $713 |
| Ipsen Biopharmaceuticals, Inc | 1 | $540 |
| Adaptive Biotechnologies Corporation | 1 | $172 |
| Taiho Oncology, Inc. | 3 | $168 |
| Sanofi-aventis U.S. LLC | 1 | $149 |
| Incyte Corporation | 2 | $129 |
| AstraZeneca | 2 | $104 |
| Astellas Pharma US Inc | 1 | $100 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $90 |
| Teva Pharmaceuticals USA, Inc. | 2 | $59 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Iovance Biotherapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,031 in reported general payments places this provider in the 85th percentile of 88 clinical nurse specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 63 | $961 |
| Pantoprazole Sodium | 18 | $174 |
| Allopurinol | 15 | $124 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Acyclovir | $59 | $96163 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 88 clinical nurse specialist providers in Texas.
Other clinical nurse specialist in Dallas
- Ashley StovallDallas$18K
- Emily SimonDallas$1K
- Norma ApplewhiteDallas$710
- Jennifer JohnsonDallas$460
- Melissa RozakisDallas$432
- Margaret McLeanDallas$283
- Rebecca MontiAustin$53K
- Martha QuintonAustin$6K
- Benjamin PaganoAustin$4K
- Donna PrebleAustin$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.